DCTH Delcath stock news
On September 25, 2026, Delcath Systems, Inc. (Nasdaq: DCTH) introduced a virtual reality (VR) procedural visualization platform at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2026 conference in Copenhagen. The interactive VR simulation is designed to immerse interventional radiologists and clinical specialists in the step--by--step workflow of the percutaneous hepatic perfusion (PHP) procedure utilizing the CHEMOSAT Hepatic Delivery System. By enhancing physician comprehension and eliminating geographic barriers to procedural training, the company aims to accelerate clinical competency and facilitate expanded adoption of its liver--directed oncology therapies.